Natural - Topical analgesic and anti-inflammatory composition F2

ABSTRACT

This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of  salix alba  (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties.

CROSS-REFERENCES

This is a continuation of U.S. patent application Ser. No. 13/565,676 dated 2013 Aug. 2.

BACKGROUND

This invention is intended provide an alternative to synthetic topical pain relief preparations. This invention contains natural, botanical extracts and essential oils in lieu of synthetic analgesics and fragrance, replacing synthetic salicin based anti-inflammatory preparations.

SUMMARY

The invention is an emulsion of natural trans-dermal carriers and analgesic and anti-inflammatory components including Salix alba (White Willow Bark) extract. The cream is compounded by combining the jojoba oil base with Salix alba (White Willow Bark), the natural botanical extracts Helicrysum Gymnocephalum, Lavendula Officinalis (Lavender), Pelargoneum Graveolens (Egyptian Geranium), Mentha Spicata (Spearmint), Eucalyptus Globulus (Eucalyptus), Rosmarinus Officinalis (Rosemary), Pimenta Racemosa, (Dominican Bay Leaf), Cymbopogon flexuosus (Lemon Grass), crystaline menthol and crystaline camphor. The invention is intended as a topical pain relief agent for external use only. It is designed to relieve muscle and joint pain when massaged into the affected area of the body and to prevent subsequent pain through the cumulative effect of the natural analgesics contained therein.

DESCRIPTION

This invention replaces the practice of utilizing synthesized salicin compounds for use as anti-inflammatory components in topical pain relief compositions through the use of naturally occurring salicin in the form of salix alba (white willow bark) botanicals. This invention is a compound of naturally occurring botanicals identified in the Natural Pharmacopeia as individually exhibiting anti-inflammatory and/or analgesic properties. The compound is unique in that the addition of Helicrysum Gymnocephalum appears to enhance the absorption of the salicin contained in Salix Alba thus providing a superior product formerly unattainable using naturally occurring salicins. This combination of Helicrysum Gymnocephalum essential oil and Salix Alba extract when combined with Eucalyptus Globules essential oil, Lavandula Angustifolia essential oil, Pelargonium Graveoleus essential oil, Mentha viridis essential oil, Pimenta Racemosa, Cymbopogon flexuosus, Camphor, and Mentha Avrensis together constitute this unique invention.

The resulting compound is then incorporated into a bulk carrier material for proper dilution and stability, and for use as a convenient delivery mechanism. The resulting compound is a shelf stable off-white viscous cream with a menthol/botanical like odor.

The invention is utilized by applying small amounts directly to areas of the human body affected by various types of pain.

The resulting compound is then incorporated into a bulk carrier material for proper dilution and stability, and for use as a convenient delivery mechanism. The resulting compound is a shelf stable off-white viscous cream with a menthol/botanical like odor.

The invention is utilized by applying small amounts directly to areas of the human body affected by various types of pain.

A complete description of included components follows:

INCI Names CAS Nos: Concentration: Water 7732 18 5  >30% to 100% Mineral Oil 8012 95 1   >3% to 10% Cetyl Alcohol 36653 82 4   >3% to 10% Stearic Acid 57 11 4   >3% to 10% Mentha Avrensis (menthol) 2216-51-5   >3% to 10% Stearyl Alcohol 112 92 5   >1% to 3% Cetearyl Alcohol 67762 27 0   >1% to 3% Cetereth 20 68339 49 6   >1% to 3% Propylene Glycol 57 55 6   >1% to 3% Camphor 76 22 2   >1% to 3% Isopropyl Palmitate 142 91 6 >0.1% to 0.3% Prunus Amygoalus Dulcis Oil 8007 69 0    >0.1 to 0.3% Glycol Monostearate S/E 111 60 4 >0.3% to 1% Phenoxy Ethanol 122 99 6 >0.3% to 1% Caprylyl Glycol 11117 86 6 >0.3% to 1% Simmondsia Chinensis (Jojoba) Seed Oil 61789 91 1   0.1% or less Salix Alba (white willow) bark extract N/A   >1% to 3% Eucalyptus Globules Oil 8000 48 4   >1% to 3% Lavandula Angustifolia (Lavender) Oil 8000 28 0 >0.3% to 1% Pelargonium Graveoleus (Geranium) Oil 8000 46 2 >0.3% to 1% Helicrysum Gymnocephalum Flower Oil N/A >0.3% to 1% Menthaviridis (Spearmint) Oil 8008 79 5 >0.3% to 1% Pimenta Racemosa 8006 78 5 >0.3% to 1% Cymbopogon flexuosus 8007 02 5 >0.3% to 1% 

1. As described in U.S. patient application Ser. No. 13/565,676 filed on Aug. 2, 2012, the combination of Helicrysum Gymnocephalum essential oil and Salix Alba extract when combined with Eucalyptus Globules essential oil, Lavandula Angustifolia essential oil, Pelargonium Graveoleus essential oil, Mentha viridis essential oil, Camphor, and Mentha Avrensis, incorporated into a cosmetic cream substrate, together constitute a unique and effective topical pain relief product.
 2. It has been found that the effects of the compound described in claim 1 above are enhanced by the addition Pimenta Racemosa, (Dominican Bay Leaf), Cymbopogon flexuosus (Lemon Grass) to said compound. Test subjects reported that the enhanced compound provides a higher level of temporary pain relief, that it is longer lasting. 